Disposition of flunixin meglumine injectable preparation administered orally to healthy horses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 27, Issue 3, 2004, Pages 183-186

  Pellegrini Masini, A ^a   Poppenga, R H ^a   Sweeney, R W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUNIXIN MEGLUMINE;

ANIMAL EXPERIMENT; ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG HALF LIFE; DRUG SYNTHESIS; HORSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CLONIXIN; CROSS-OVER STUDIES; FEMALE; HORSES; INJECTIONS, INTRAVENOUS;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 3042832073     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2004.00575.x     Document Type: Article

References (21)

1. Boeckh, C., Buchanan, C., Boeckh, A., Wilkie, S., Davis, C., Buchanan, T. & Boothe, D. (2001) Pharmacokinetics of the bovine formulation of enrofloxacin (Baytrill®100) in horses. Veterinary Therapeutics, 2, 129-134.
2. Bottoms, G.D., Fessler, J.F., Roesel, O.F., Moore, A.B. & Frauenfelder, H.C. (1981) Endotoxin-induced hemodynamic changes in ponies: effects of flunixin meglumine. American Journal of Veterinary Research, 42, 1514-1518.
3. Brooks, D.E. (1998) Equine ophthalmology. In Veterinary Ophthalmology, 3rd edn. Ed. Gelatt, K.N. pp. 1053-1116. Lippincott, Williams and Wilkins, Baltimore.
4. Bruehaus, B.A., Brown, C.M., Scott, E.A., Ainsworth, D.M. & Taylor, R.F. (1983) Clostridial muscle infections following intramuscular injections in the horse. Journal of Equine Veterinary Science, 3, 42-46.
5. Clark, J.O. & Clark, T.P. (1999) Analgesia. Veterinary Clinics of North America: Equine Practice, 15, 705-723.
6. Dyke, T.M., Sams, R.A. & Cosgrove, S.B. (1997) Disposition of flunixin after intramuscular administration of flunixin meglumine to horses. Journal of Veterinary Pharmacology and Therapeutics, 20, 330-332.
7. Fessler, J.F., Bottoms, G.D., Roesel, O.F., Moore, A.B., Frauenfelder, H.C. & Boon, G.D. (1982) Endotoxin-induced change in hemograms, plasma enzymes, and blood chemical values in anesthetized ponies: effects of flunixin meglumine. American Journal of Veterinary Research. 43, 140-144.
8. Houdeshell, J.W. & Hennessey, B.S. (1977) A new non-steroidal, antiinflammatory analgesic for horses. Journal of Equine Medicine and Surgery, 1, 57-63.
9. Johnstone, I.B. (1983) Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro. Canadian Journal of Veterinary Research, 47, 172-179.
10. Laktriz, J., Wilson, W.D., Marsh, A.E. & Milhalyi, J.E. (2000) Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals. American Journal of Veterinary Research, 61, 914-919.
11. Moore, J.N., Garner, H.E., Shapland, J.E. & Hatfield, D.G. (1982) Prevention of endotoxin-induced arterial hypoxemia and lactic acidosis with flunixin meglumine in the conscious pony. Equine Veterinary Journal, 13, 95-98.
12. Reimer, J.M. & Sweeney, R.W. (1992) Pharmacokinetics of Phenobarbital after repeated oral administration in normal horses. Journal of Veterinary Pharmacology and Therapeutics, 15, 301-304.
13. Semrad, S.D., Hardee, G.E., Hardee, M.S. & Moore, J.N. (1985) Flunixin meglumine given in small doses: pharmacokinetic and prostaglandin inhibition In healthy horses. American Journal of Veterinary Research, 46, 2474-2479.
14. Shuster, R., Traub-Dargatz, J. & Baxter, G. (1997) Survey of diplomats of the American College of Veterinary Internal Medicine and the American College of Veterinary Surgeons regarding clinical aspects and treatment of endotoxemia in horses. Journal of the American Veterinary Medical Association, 210, 87-92.
15. Soma, L.R., Behrend, E., Rudy, J. & Sweeney, R.W. (1988) Disposition and excretion of flunixin meglumine in horses. American Journal of Veterinary Research, 49, 1894-1898.
16. Sweeney, R.W., Reef, V.B. & Reimer, J.M. (1993) Pharmacokinetics of digoxin administered to horses with congestive heart failure. American Journal of Veterinary Research, 54, 1108-1111.
17. Taiwo, Y.O. & Levine, J.D. (1988) Prostaglandin inhibit endogenous pain control mechanism by blocking transmission at spinal noradrenergic synapses. Journal of Neuroscience, 8, 1346-1349.
18. Toutain, L., Autefage, A., Legrand, C. & Alvinerie, M. (1994) Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modeling. Journal of Veterinary Pharmacology and Therapeutics, 17, 459-469.
19. Turek, J.J., Templeton, C.B., Bottoms, G.D. & Fessler, J.F. (1985) Flunixin meglumine attenuation of endotoxin-induced damage to the cardiopulmonary vasculature endothelium of the pony. American Journal of Veterinary Research, 46, 591-596.
20. Vernimb, G.D. & Hennessey, B.S. (1977) Clinical studies on flunixin meglumine in the treatment of equine colic. Journal of Equine Medicine and Surgery, 1, 111-116.
21. Welsh, J.M.C., Lees, P., Stodulski, G., Cambridge, H. & Foster, A.P. (1992) Influence of feeding schedule on the absorption of orally administered flunixin in the horse. Equine Veterinary Journal Supplement (Equine Pharmacology), 11, 62-65.